This information was published on 2025-12-18T04:53:12 for IP Right Filed Published.
| Field | Value |
| (210) | 2613289 (IR 1892344) |
| (220) |
21 Nov 2025
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of mitochondrial disorders; pharmaceutical preparations and substances for treatment of genetic diseases; pharmaceutical preparations for the treatment of diseases or dysfunction of the mitochondria; pharmaceutical preparations featuring cell penetrating peptides for use in the treatment of genetic disorders; pharmaceuticals that treat genetic diseases by use of carrier proteins; pharmaceutical preparations for the treatment of ataxia; pharmaceutical preparations for the treatment of Friedreich's Ataxia; pharmaceutical preparations for protein replacement therapy; pharmaceutical preparations for frataxin replacement therapy. |
| (540) | FRAXLANZA |
| (550) | Word |
| (730) |
Larimar Therapeutics, Inc.
|
Find out more about publications on the About page.